Literature DB >> 30616501

Medical Cannabis Users' Comparisons between Medical Cannabis and Mainstream Medicine.

Daniel J Kruger1, Jessica S Kruger2.   

Abstract

An evidence-based approach is needed to shape policies and practices regarding medical cannabis, thereby reducing harm and maximizing benefits to individuals and society. This project assesses attitudes towards and utilization of medical cannabis and the mainstream healthcare system among medical cannabis users. The research team administered brief hard copy surveys to 450 adults attending an annual public event advocating for cannabis law reform. Among usable responses (N = 392), the majority (78%) reported using cannabis to help treat a medical or health condition. Medical cannabis users reported a greater degree of use of medical cannabis and a greater degree of trust in medical cannabis compared to mainstream healthcare. In comparison to pharmaceutical drugs, medical cannabis users rated cannabis better on effectiveness, side effects, safety, addictiveness, availability, and cost. Due to the medical use of cannabis, 42% stopped taking a pharmaceutical drug and 38% used less of a pharmaceutical drug. A substantial proportion (30%) reported that their mainstream healthcare provider did not know that they used medical cannabis. Other issues identified included lack of access to mainstream healthcare, self-initiated treatment of health issues, little knowledge of psychoactive content, and heavy cannabis use.

Entities:  

Keywords:  Attitudes; cannabis; complimentary medicine; health; marijuana

Mesh:

Substances:

Year:  2019        PMID: 30616501     DOI: 10.1080/02791072.2018.1563314

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  7 in total

1.  Demographics, Perceptions, and Use of Medical Marijuana among Patients in Florida.

Authors:  Martha S Rosenthal; R Nathan Pipitone
Journal:  Med Cannabis Cannabinoids       Date:  2020-12-22

2.  Assessing Health Care Providers' Knowledge of Medical Cannabis.

Authors:  Daniel J Kruger; Majd A Mokbel; Daniel J Clauw; Kevin F Boehnke
Journal:  Cannabis Cannabinoid Res       Date:  2021-08-31

3.  Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context.

Authors:  Alexis Holman; Daniel J Kruger; Philippe Lucas; Kaye Ong; Rachel S Bergmans; Kevin F Boehnke
Journal:  J Cannabis Res       Date:  2022-06-13

4.  Slovenian Pet Owners' Experience, Attitudes, and Predictors Regarding Cannabinoid Use in Dogs and Cats.

Authors:  Katerina Tomsič; Kristina Rakinić; Alenka Seliškar
Journal:  Front Vet Sci       Date:  2022-01-05

5.  Delta-8-THC: Delta-9-THC's nicer younger sibling?

Authors:  Jessica S Kruger; Daniel J Kruger
Journal:  J Cannabis Res       Date:  2022-01-04

6.  Young adults' familiarity with different cannabis product terms: the need for standardized cannabis surveys.

Authors:  S Berberian; M L Broussard; C Tully; V Methuku; D A Pardini; M H Meier
Journal:  J Cannabis Res       Date:  2022-04-01

7.  An Observational Cross-Sectional Survey Exploring the Indications for and Responses to Medical Marijuana Use in Certified Patients in Pennsylvania.

Authors:  Debra Kimless; Matthew Caloura; Virginia Markos; Jennie Ryan; Sally Abbonizio; Sharon Janicki
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.